Rating History for Syros Pharmaceuticals (SYRS) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/13/2024 | Andrew Fein | Downgrade | Neutral (Buy) |
1.00 (6.00) |
2.73 (0.12) |
-95.6% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/13/2024 | Andrew Fein | Downgrade | Neutral (Buy) |
1.00 (6.00) |
2.73 (0.12) |
-95.6% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||